<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36751643</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2514-1775</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Rheumatology advances in practice</Title><ISOAbbreviation>Rheumatol Adv Pract</ISOAbbreviation></Journal><ArticleTitle>The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic.</ArticleTitle><Pagination><StartPage>rkad009</StartPage><MedlinePgn>rkad009</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">rkad009</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/rap/rkad009</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The aim was to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic and stringent social isolation measures on patients with rheumatic disease (RD) from the beginning of the pandemic (April 2020).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this UK-based single-centre, prospective, observational cohort study, all RD follow-up patients at our centre were invited by SMS text message in April 2020 to participate in the study. Participants completed questionnaires at four time points between April 2020 and December 2021. We collected demographics, clinically extremely vulnerable (CEV) status, short form 12 mental (MCS) and physical health component scores (PCS) for health-related quality of life, vaccination status, COVID-19 infection rates and incidence of long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We enrolled 1605 patients (female, 69.0%; CEV, 46.5%); 906 of 1605 (56.4%) completed linked responses to our final questionnaire. MCS improved (+0.6, <i>P</i>&#x2009;&lt;&#x2009;0.05), whereas PCS scores deteriorated (-1.4, <i>P</i>&#x2009;&lt;&#x2009;0.001) between April 2020 and December 2021. CEV patients had worse mental and physical health scores than non-CEV patients at entry (PCS, 36.7 and 39.3, respectively, <i>P</i>&#x2009;&lt;&#x2009;0.001; MCS, 40.9 and 43.0, respectively, <i>P</i>&#x2009;&lt;&#x2009;0.001) and at each time point throughout the study; both mental and physical health outcomes were worse in CEV compared with non-CEV patients (<i>P</i>&#x2009;&lt;&#x2009;0.001 and <i>P</i>&#x2009;=&#x2009;0.004, respectively). At study close, 148 of 906 (16.3%) reported COVID infection, with no difference in infection, vaccination or long COVID rates between CEV and non-CEV patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Mental and physical health in RD patients has changed throughout the pandemic; outcomes for both metrics of health were worse in CEV patients, although there were no differences in infection rates between the groups. These data might assist the understanding and planning of future health-care policy and social restrictions in RD patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">ClinicalTrials.gov, www.clinicaltrials.gov, NCT04542031.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, Newcastle-under-Lyme, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raizada</LastName><ForeName>Sabrina R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-7911-2819</Identifier><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barkham</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatachalam</LastName><ForeName>Srinivasan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheeran</LastName><ForeName>Tom P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adizie</LastName><ForeName>Tochukwu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapkota</LastName><ForeName>Hem</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2314-2637</Identifier><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Ian C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, Newcastle-under-Lyme, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6645-5751</Identifier><AffiliationInfo><Affiliation>Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, Newcastle-under-Lyme, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1952-2821</Identifier><AffiliationInfo><Affiliation>The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04542031</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rheumatol Adv Pract</MedlineTA><NlmUniqueID>101736676</NlmUniqueID><ISSNLinking>2514-1775</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SMS communications</Keyword><Keyword MajorTopicYN="N">health policy</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">patient outcomes</Keyword><Keyword MajorTopicYN="N">rheumatic disease</Keyword><Keyword MajorTopicYN="N">stringent social isolation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36751643</ArticleId><ArticleId IdType="pmc">PMC9897299</ArticleId><ArticleId IdType="doi">10.1093/rap/rkad009</ArticleId><ArticleId IdType="pii">rkad009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Institute for Government. Timeline of UK government coronavirus lockdowns and restrictions. 2022. https://www.instituteforgovernment.org.uk/charts/uk-government-coronavirus-lockdowns (6 June 2022, date last accessed).</Citation></Reference><Reference><Citation>
NHS England. Clinical guide for the management of rheumatology patients during the coronavirus pandemic. 2020. https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/clinical-guide-rheumatology-patients-v1-19-march-2020.pdf (6 June 2022, date last accessed).</Citation></Reference><Reference><Citation>
NHS Digital. Shielded Patient List. 2021. https://digital.nhs.uk/coronavirus/shielded-patient-list (10 June 2022, date last accessed).</Citation></Reference><Reference><Citation>
NHS England. Information about the end of the shielding programme and managing the closure of the Shielded Patient List. 2021. https://www.england.nhs.uk/coronavirus/documents/information-about-the-end-of-the-shielding-programme-and-managing-the-closure-of-the-shielded-patient-list/ (10 June 2022, date last accessed).</Citation></Reference><Reference><Citation>Ziade N, El Khoury B, Zoghbi M. et al. Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study. Sci Rep 2020;10:7683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7203228</ArticleId><ArticleId IdType="pubmed">32376850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingegnoli F, Buoli M, Posio C. et al. COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project. BMC Psychiatry 2021;21:385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8330176</ArticleId><ArticleId IdType="pubmed">34344329</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone G, Treharne GJ, Fletcher BD. et al. Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown. Rheumatol Int 2021;41:1763&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298198</ArticleId><ArticleId IdType="pubmed">34297180</ArticleId></ArticleIdList></Reference><Reference><Citation>Guaracha-Bas&#xe1;&#xf1;ez GA, Contreras-Y&#xe1;&#xf1;ez I, Hern&#xe1;ndez-Molina G. et al. Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: the biopsychosocial path. PLoS One 2022;17:e0262756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8765619</ArticleId><ArticleId IdType="pubmed">35041692</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleaton N, Raizada S, Barkham N. et al. The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding. Rheumatol Int 2021;41:707&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871319</ArticleId><ArticleId IdType="pubmed">33559727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M, Carpenter L, de Souza S. et al. The impact of COVID-19 on clinical care, self-management and mental health of patients with inflammatory arthritis. Rheumatol Adv Pract 2022;6:rkab095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690299</ArticleId><ArticleId IdType="pubmed">35043091</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison SR, Garrido-Cumbrera M, Navarro-Comp&#xe1;n V. et al. Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1). Rheumatol Adv Pract 2021;5:rkab098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690324</ArticleId><ArticleId IdType="pubmed">34988357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman J, Cleaton N.. Managing patients using telerheumatology: lessons from a pandemic. Best Pract Res Clin Rheumatol 2021;35:101662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993644</ArticleId><ArticleId IdType="pubmed">33526324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman J, Mulherin D, Hirsch G, Venkatachalam S, Sheeran T.. Rapid distribution of information by SMS-embedded video link to patients during a pandemic. Lancet Rheumatol 2020;2:e315&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202853</ArticleId><ArticleId IdType="pubmed">32382726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman J, Cox N, Rajagopala L. et al. COVID-19 vaccination advice via SMS-based video to improve vaccination uncertainty in at-risk groups. Lancet Rheumatol 2021;3:e399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8159190</ArticleId><ArticleId IdType="pubmed">34075360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JJ, Kosinski M, Keller SD.. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JJ, Kosinski M, Keller SD.. How to score the SF-12 physical &amp; mental health summary scales. 2nd edn.Boston, MA: The Health Institute, New England Medical Center, 1995.</Citation></Reference><Reference><Citation>
National Institute of Clinical Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188] 2020. https://www.nice.org.uk/guidance/ng188 (15 June 2022, date last accessed).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>
British Society for Rheumatology. COVID-19 - Identifying patients for shielding in England. 2020. https://www.rheumatology.org.uk/Portals/0/Documents/COVID-19/Rheumatology_advice_coronavirus_immunosuppressed_patients_220320.pdf?ver=2020-03-24-171132-407 (6 June 2022, date last accessed).</Citation></Reference><Reference><Citation>Lewis KJS, Lewis C, Roberts A. et al. The effect of the COVID-19 pandemic on mental health in individuals with pre-existing mental illness. BJPsych Open 2022;8:e59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8914135</ArticleId><ArticleId IdType="pubmed">35249586</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia R, Ayling K, Chalder T. et al. Mental health in the UK during the COVID-19 pandemic: cross-sectional analyses from a community cohort study. BMJ Open 2020;10:e040620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7493070</ArticleId><ArticleId IdType="pubmed">32933965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan M, Gordon C, Lever E. et al. COVID-19 and shielding: experiences of UK patients with lupus and related diseases. Rheumatol Adv Pract 2021;5:rkab003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928599</ArticleId><ArticleId IdType="pubmed">33728396</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge RW, Lewer D, Katikireddi SV. et al. Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Wellcome Open Res 2020;5:88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317462</ArticleId><ArticleId IdType="pubmed">32613083</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatti FB, Pedersen BK.. Exercise as an anti-inflammatory therapy for rheumatic diseases&#x2014;myokine regulation. Nat Rev Rheumatol 2015;11:86&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">25422002</ArticleId></ArticleIdList></Reference><Reference><Citation>Turesson C, Matteson EL.. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Curr Opin Rheumatol 2007;19:190&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17278937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K, Venkatachalam S, Sheeran T, Bateman J.. 170&#x2003;How do we plan outpatient rheumatology services? An electronic case-mix service evaluation of more than 1000 consecutive new and follow-up clinics slots. Rheumatology 2016;55(suppl 1):i130&#x2013;1.</Citation></Reference><Reference><Citation>Busija L, Ackerman IN, Haas R. et al. Adult measures of general health and health-related quality of life. Arthritis Care Res 2020;72:522&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33091274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bexelius C, Merk H, Sandin S. et al. SMS versus telephone interviews for epidemiological data collection: feasibility study estimating influenza vaccination coverage in the Swedish population. Eur J Epidemiol 2009;24:73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">19082745</ArticleId></ArticleIdList></Reference><Reference><Citation>Hlatshwako TG, Shah SJ, Kosana P. et al. Online health survey research during COVID-19. Lancet Digit Health 2021;3:e76&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10000261</ArticleId><ArticleId IdType="pubmed">33509387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>